Statin therapy does not influence the outcome of patients undergoing surgery for pancreatic cancer.

Dimitrios KaraviasPaul ThomasAmanda KohGlen IrvingAlex P NavarroIain C CameronDhanny Gomeznull null

Published in: ANZ journal of surgery (2019)

Adjuvant chemotherapy is an independent predictor of overall survival in patients undergoing surgery for pancreatic cancer. Statin therapy does not influence survival outcomes and histopathological characteristics following surgery for pancreatic cancer.

Keyphrases

patients undergoing
minimally invasive
coronary artery bypass
cardiovascular disease
surgical site infection
coronary artery disease
type diabetes
bone marrow
replacement therapy
smoking cessation